Skip to main content

Scientists Discover Enzyme to Supercharge Diabetes Medications

Published on June 22, 2026, 1:43 p.m.
Scientists Discover Enzyme to Supercharge Diabetes Medications

Topic: Biology

Researchers at the University of Utah found an enzyme called PapB that can link ends of therapeutic peptides into tight rings. This makes medicines like Ozempic more durable and effective.

Scientists have discovered a new way to improve how diabetes medications work in the body. Researchers at the University of Utah identified an enzyme called PapB that can reshape therapeutic peptides, which are protein-like drugs used to treat diabetes and obesity. These peptides are often linked together into rings, known as macrocyclization, to create compact structures that perform better in the body. The discovery could be especially useful for enhancing GLP-1 medications like semaglutide, the active ingredient in Ozempic and Wegovy.

Ring-shaped peptides offer several advantages over their open-chain counterparts. They are more stable, remain active longer, and can better interact with biological targets. This is because ring-shaped structures are less prone to degradation or breakdown, making them more effective at treating diseases.

The team tested PapB on three different GLP-1-like peptides and found that the enzyme successfully converted linear molecules into ring-shaped versions. These results indicate that PapB could function as a flexible, plug-and-play tool for modifying peptides even at late stages of drug development.

Why It Matters

This discovery has the potential to improve how diabetes medications work in the body, making them more effective and durable. This is especially important in India, where diabetes is a growing concern and access to quality healthcare can be limited.

Key Facts

  • Researchers at the University of Utah discovered an enzyme called PapB that can link ends of therapeutic peptides into tight rings.
  • PapB can create compact structures that make medicines like Ozempic more durable and effective.
  • Ring-shaped peptides are more stable, remain active longer, and can better interact with biological targets.
  • The team tested PapB on three different GLP-1-like peptides and found that the enzyme successfully converted linear molecules into ring-shaped versions.
  • This discovery has the potential to improve how diabetes medications work in the body.

Key Terms

Macrocyclization
The process of linking ends of therapeutic peptides into tight rings.

Implications

This discovery has the potential to improve how diabetes medications work in the body, making them more effective and durable. This is especially important in India, where diabetes is a growing concern and access to quality healthcare can be limited.


Source: https://www.sciencedaily.com/releases/2026/04/260427050620.htm

Journal Reference:

  1. Jacob K. Pedigo, Karsten A. S. Eastman, Vahe Bandarian. Leader-Independent C-Terminal Modification by a Radical S-Adenosyl-l-methionine Maturase Enables Macrocyclic GLP-1-Like Peptides. ACS Bio, 2025; 5 (6): 1007 DOI: 10.1021/acsbiomedchemau.5c00152

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.